LobbyingBaxter International lobbying by quarter
Baxter International BAX's latest lobbying report covers Q3 2026, at $10K. The four quarters Q4 2025–Q3 2026 total $100K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Baxter InternationalBAX
- Latest quarter
- $10K
- Q3 2026 · 1 reports
- Last 12 months
- $100K
- Last 4 quarters
- vs last quarter
- −66.7%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 1 |
| Q1 2023 | $30K | 1 |
| Q2 2023 | $30K | 1 |
| Q3 2023 | $30K | 1 |
| Q4 2023 | $30K | 1 |
| Q1 2024 | $30K | 1 |
| Q2 2024 | $30K | 1 |
| Q3 2024 | $30K | 1 |
| Q4 2024 | $30K | 1 |
| Q1 2025 | $30K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $10K | 1 |
By issue
- Health issues$230K · 16 reports
- Medicare and Medicaid$230K · 16 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)16 reports
- Health & Human Services, Dept of (HHS)16 reports
Firms it paid
| Firm | ||
|---|---|---|
| McDermott+ | $460K | 16 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/27for Q3 | McDermott+ | $10K |
| 07/08for Q2 | McDermott+ | $30K |
| 04/16for Q1 | McDermott+ | $30K |
| 04/07for Q1 | McDermott+ | $30K |
| 01/12for Q4 2025 | McDermott+ | $30K |
| 25/10/03for Q3 2025 | McDermott+ | $30K |
| 25/06/27for Q2 2025 | McDermott+ | $30K |
| 25/03/31for Q1 2025 | McDermott+ | $30K |
| 25/01/06for Q4 2024 | McDermott+ | $30K |
| 24/10/03for Q3 2024 | McDermott+ | $30K |
| 24/10/03for Q3 2024 | McDermott+ | $30K |
| 24/07/08for Q2 2024 | McDermott+ | $30K |
| 24/04/05for Q1 2024 | McDermott+ | $30K |
| 24/01/02for Q4 2023 | McDermott+ | $30K |
| 23/10/02for Q3 2023 | McDermott+ | $30K |
| 23/06/30for Q2 2023 | McDermott+ | $30K |
| 23/04/13for Q1 2023 | McDermott+ | $30K |
| 23/01/11for Q4 2022 | McDermott+ | $30K |